Found: 3
Select item for more details and to access through your institution.
Scientific considerations for complex drugs in light of established and emerging regulatory guidance.
- Published in:
- Annals of the New York Academy of Sciences, 2013, v. 1276, n. 1, p. 26, doi. 10.1111/j.1749-6632.2012.06811.x
- By:
- Publication type:
- Article
EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B‐Cell Lymphoma.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. 894, doi. 10.1634/theoncologist.2019-0646
- By:
- Publication type:
- Article
The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
- Published in:
- Oncologist, 2016, v. 21, n. 1, p. 102, doi. 10.1634/theoncologist.2015-0276
- By:
- Publication type:
- Article